Biomarin

Twin Orphan Drug News
Motley Fool
Sat, 09/29/12 - 11:50 am
Biomarin
orphan drugs
Peg-Pal
phenylketonuria
Kuvan
Biomarin: Four Clinical Trial Events to Watch Before Year End
TheStreet.com
Tue, 09/25/12 - 11:27 am
Biomarin
BMN-111
GALNs
BMRN-763
Peg-Pal
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
arclays Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight; Three Shots on Goal
Street Insider
Sat, 08/25/12 - 12:50 pm
Biomarin
3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha
Tue, 08/21/12 - 11:33 am
Biomarin
China Biologic
Anika
BioMarin Pharmaceuticals Inc: Today's Featured Health Care Laggard
The Street
Sat, 08/11/12 - 12:03 pm
Biomarin
Bio Buyouts
Motley Fool
Sun, 07/29/12 - 12:10 pm
Seattle Genetics
Alexion
Regeneron
Biomarin
Vertex Pharmaceuticals
Idenix
Obagi Medical Products
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Fri, 07/27/12 - 11:55 am
Vivus
Biomarin
Alkermes
Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model
Street Insider
Sun, 07/15/12 - 12:02 pm
BMN-701
Biomarin
Pompe disease
GlaxoSmithKline rises on US and Europe drug submission, amid renewed talk of interest in Biomarin
Guardian, UK
Fri, 07/13/12 - 12:30 pm
GSK
Biomarin
M&A
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thu, 06/28/12 - 12:49 pm
GSK
Biomarin
M&A
Shire
BioMarin Higher as GSK Takeover Chatter Swirls
StreetInsider.com
Tue, 06/12/12 - 12:48 pm
GSK
Biomarin
M&A
BioMarin Prices Share Offering - Analyst Blog
NASDAQ
Sun, 06/3/12 - 12:24 pm
Biomarin
BioMarin to Raise Funds
Yahoo/Zacks
Thu, 05/31/12 - 06:15 pm
Biomarin
stock offering
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Sat, 05/19/12 - 12:36 pm
Halozyme
Novavax
Prolor
Valeant Pharmaceuticals
Myrexis
OPKO Health
Vertex Pharmaceuticals
Edwards Lifesciences
Medivation
Biomarin
Mylan
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Bacterin
Biomarin
Athersys
Affymax
Acorda Therapeutics
Alexion
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Seeking Alpha
Sun, 05/13/12 - 01:36 pm
Seattle Genetics
Biomarin
Jazz Pharmaceuticals
Illumina
Questcor Pharmaceuticals
Vivus
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Biomarin
Amicus Therapeutics
Sanofi
Vertex
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Pharmabiz
Sat, 03/10/12 - 06:47 pm
Biomarin
mucopolysaccharidosis
Morquio A Syndrome
BMN-110

Pages